These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 23989451)
1. A real-time, fluorescence-based assay for measuring μ-opioid receptor modulation of adenylyl cyclase activity in Chinese hamster ovary cells. Knapman A; Abogadie F; McIntrye P; Connor M J Biomol Screen; 2014 Feb; 19(2):223-31. PubMed ID: 23989451 [TBL] [Abstract][Full Text] [Related]
2. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling. Szücs M; Boda K; Gintzler AR J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951 [TBL] [Abstract][Full Text] [Related]
3. Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment. Shy M; Chakrabarti S; Gintzler AR Mol Pharmacol; 2008 Mar; 73(3):868-79. PubMed ID: 18045853 [TBL] [Abstract][Full Text] [Related]
4. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells. Cinar R; Szücs M J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142 [TBL] [Abstract][Full Text] [Related]
5. Fluorescence-based, high-throughput assays for μ-opioid receptor activation using a membrane potential-sensitive dye. Knapman A; Connor M Methods Mol Biol; 2015; 1230():177-85. PubMed ID: 25293325 [TBL] [Abstract][Full Text] [Related]
6. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells. Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374 [TBL] [Abstract][Full Text] [Related]
7. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor. Xu H; Lu YF; Rothman RB Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367 [TBL] [Abstract][Full Text] [Related]
9. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells. Clark MJ; Traynor JR J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633 [TBL] [Abstract][Full Text] [Related]
10. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase. Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231 [TBL] [Abstract][Full Text] [Related]
11. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor. Xu H; Wang X; Wang J; Rothman RB Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220 [TBL] [Abstract][Full Text] [Related]
12. Differential opioid agonist regulation of the mouse mu opioid receptor. Blake AD; Bot G; Freeman JC; Reisine T J Biol Chem; 1997 Jan; 272(2):782-90. PubMed ID: 8995364 [TBL] [Abstract][Full Text] [Related]
13. Adaptations to chronic agonist exposure of mu-opioid receptor-expressing Chinese hamster ovary cells. Kato S; Fukuda K; Morikawa H; Shoda T; Mima H; Mori K Eur J Pharmacol; 1998 Mar; 345(2):221-8. PubMed ID: 9600641 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors. Zádor F; Otvös F; Benyhe S; Zimmer A; Páldy E Neurochem Int; 2012 Aug; 61(3):378-88. PubMed ID: 22613132 [TBL] [Abstract][Full Text] [Related]
15. 3H-naloxone benzoylhydrazone binding in MOR-1-transfected Chinese hamster ovary cells: evidence for G-protein-dependent antagonist binding. Brown GP; Pasternak GW J Pharmacol Exp Ther; 1998 Jul; 286(1):376-81. PubMed ID: 9655882 [TBL] [Abstract][Full Text] [Related]